HEADER VIRAL PROTEIN 16-JUL-21 7FDG TITLE SARS-COV-2 SPIKE RBDMACSP6 BINDING TO HACE2 COMPND MOL_ID: 1; COMPND 2 MOLECULE: ANGIOTENSIN-CONVERTING ENZYME 2; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: ANGIOTENSIN-CONVERTING ENZYME HOMOLOG,ACEH,ANGIOTENSIN- COMPND 5 CONVERTING ENZYME-RELATED CARBOXYPEPTIDASE,ACE-RELATED COMPND 6 CARBOXYPEPTIDASE,METALLOPROTEASE MPROT15; COMPND 7 EC: 3.4.17.23,3.4.17.-; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: SPIKE PROTEIN S1; COMPND 11 CHAIN: E; COMPND 12 ENGINEERED: YES; COMPND 13 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ACE2, UNQ868/PRO1885; SOURCE 6 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS SOURCE 10 2; SOURCE 11 ORGANISM_COMMON: 2019-NCOV, SARS-COV-2; SOURCE 12 ORGANISM_TAXID: 2697049; SOURCE 13 GENE: S, 2; SOURCE 14 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 15 EXPRESSION_SYSTEM_TAXID: 9606 KEYWDS SARS-COV-2 SPIKE, MOUSE-ADAPTED, RBD, ACE2, VIRUS PROTEIN, VIRUS, KEYWDS 2 VIRAL PROTEIN EXPDTA ELECTRON MICROSCOPY AUTHOR X.WANG,L.CAO REVDAT 2 23-MAR-22 7FDG 1 JRNL REVDAT 1 25-AUG-21 7FDG 0 JRNL AUTH S.SUN,H.GU,L.CAO,Q.CHEN,Q.YE,G.YANG,R.T.LI,H.FAN,Y.Q.DENG, JRNL AUTH 2 X.SONG,Y.QI,M.LI,J.LAN,R.FENG,Y.GUO,N.ZHU,S.QIN,L.WANG, JRNL AUTH 3 Y.F.ZHANG,C.ZHOU,L.ZHAO,Y.CHEN,M.SHEN,Y.CUI,X.YANG,X.WANG, JRNL AUTH 4 W.TAN,H.WANG,X.WANG,C.F.QIN JRNL TITL CHARACTERIZATION AND STRUCTURAL BASIS OF A LETHAL JRNL TITL 2 MOUSE-ADAPTED SARS-COV-2. JRNL REF NAT COMMUN V. 12 5654 2021 JRNL REFN ESSN 2041-1723 JRNL PMID 34580297 JRNL DOI 10.1038/S41467-021-25903-X REMARK 2 REMARK 2 RESOLUTION. 3.69 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : NULL REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : NULL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 3.690 REMARK 3 NUMBER OF PARTICLES : 162615 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 7FDG COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 19-JUL-21. REMARK 100 THE DEPOSITION ID IS D_1300023330. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : SARS-COV-2 SPIKE RBDMACSP6 REMARK 245 -HACE2 COMPLEX REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : NULL REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 7.50 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : FEI TITAN REMARK 245 DETECTOR TYPE : GATAN K2 BASE (4K X 4K) REMARK 245 MINIMUM DEFOCUS (NM) : NULL REMARK 245 MAXIMUM DEFOCUS (NM) : NULL REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : NULL REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 6000.00 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 SER A 2 REMARK 465 SER A 3 REMARK 465 SER A 4 REMARK 465 SER A 5 REMARK 465 TRP A 6 REMARK 465 LEU A 7 REMARK 465 LEU A 8 REMARK 465 LEU A 9 REMARK 465 SER A 10 REMARK 465 LEU A 11 REMARK 465 VAL A 12 REMARK 465 ALA A 13 REMARK 465 VAL A 14 REMARK 465 THR A 15 REMARK 465 ALA A 16 REMARK 465 ALA A 17 REMARK 465 GLN A 18 REMARK 465 HIS A 616 REMARK 465 HIS A 617 REMARK 465 HIS A 618 REMARK 465 HIS A 619 REMARK 465 HIS A 620 REMARK 465 HIS A 621 REMARK 465 MET E 320 REMARK 465 PHE E 321 REMARK 465 VAL E 322 REMARK 465 PHE E 323 REMARK 465 LEU E 324 REMARK 465 VAL E 325 REMARK 465 LEU E 326 REMARK 465 LEU E 327 REMARK 465 PRO E 328 REMARK 465 LEU E 329 REMARK 465 VAL E 330 REMARK 465 SER E 331 REMARK 465 SER E 332 REMARK 465 HIS E 527 REMARK 465 HIS E 528 REMARK 465 HIS E 529 REMARK 465 HIS E 530 REMARK 465 HIS E 531 REMARK 465 HIS E 532 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 MET A 152 CG SD CE REMARK 470 ARG A 161 CG CD NE CZ NH1 NH2 REMARK 470 MET A 270 CG SD CE REMARK 470 ASN A 437 CG OD1 ND2 REMARK 470 GLU A 495 CG CD OE1 OE2 REMARK 470 GLN A 524 CG CD OE1 NE2 REMARK 470 GLU A 527 CG CD OE1 OE2 REMARK 470 LEU A 558 CG CD1 CD2 REMARK 470 GLN E 506 CG CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O THR A 118 OG1 THR A 122 2.06 REMARK 500 O ASN A 103 OG SER A 106 2.09 REMARK 500 OH TYR A 41 OG1 THR E 500 2.14 REMARK 500 O HIS A 417 OG SER A 420 2.14 REMARK 500 O THR A 449 OG1 THR A 453 2.16 REMARK 500 OD2 ASP A 543 OG SER A 545 2.17 REMARK 500 NH2 ARG A 245 O GLY A 260 2.18 REMARK 500 O THR A 125 OG1 THR A 129 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 CYS A 141 CA - CB - SG ANGL. DEV. = 7.5 DEGREES REMARK 500 CYS E 379 CA - CB - SG ANGL. DEV. = 9.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 81 -7.64 -58.35 REMARK 500 GLN A 102 98.90 -67.86 REMARK 500 PRO A 135 1.10 -67.12 REMARK 500 ALA A 153 -62.18 -92.98 REMARK 500 TYR A 215 19.90 -142.43 REMARK 500 TYR A 255 12.09 -141.59 REMARK 500 CYS A 261 -172.50 -69.96 REMARK 500 TRP A 271 -34.87 -135.02 REMARK 500 CYS A 344 35.09 -99.66 REMARK 500 TYR A 385 35.19 -95.65 REMARK 500 PRO A 389 170.46 -56.84 REMARK 500 ASP A 427 34.28 -99.71 REMARK 500 ASP A 471 1.22 -62.29 REMARK 500 HIS A 540 -8.82 -59.93 REMARK 500 ARG A 559 1.90 -67.46 REMARK 500 ALA A 614 59.23 -90.77 REMARK 500 ALA E 372 12.27 55.84 REMARK 500 ASP E 389 46.51 -93.98 REMARK 500 ALA E 411 147.86 -170.79 REMARK 500 SER E 438 28.60 -140.22 REMARK 500 ALA E 522 98.47 -66.53 REMARK 500 CYS E 525 -179.07 -176.85 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 CYS E 379 TYR E 380 -148.87 REMARK 500 VAL E 524 CYS E 525 143.31 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-31542 RELATED DB: EMDB REMARK 900 SARS-COV-2 SPIKE RBDMACSP6 BINDING TO HACE2 DBREF 7FDG A 1 615 UNP Q9BYF1 ACE2_HUMAN 1 615 DBREF 7FDG E 333 526 UNP P0DTC2 SPIKE_SARS2 333 526 SEQADV 7FDG HIS A 616 UNP Q9BYF1 EXPRESSION TAG SEQADV 7FDG HIS A 617 UNP Q9BYF1 EXPRESSION TAG SEQADV 7FDG HIS A 618 UNP Q9BYF1 EXPRESSION TAG SEQADV 7FDG HIS A 619 UNP Q9BYF1 EXPRESSION TAG SEQADV 7FDG HIS A 620 UNP Q9BYF1 EXPRESSION TAG SEQADV 7FDG HIS A 621 UNP Q9BYF1 EXPRESSION TAG SEQADV 7FDG MET E 320 UNP P0DTC2 INITIATING METHIONINE SEQADV 7FDG PHE E 321 UNP P0DTC2 EXPRESSION TAG SEQADV 7FDG VAL E 322 UNP P0DTC2 EXPRESSION TAG SEQADV 7FDG PHE E 323 UNP P0DTC2 EXPRESSION TAG SEQADV 7FDG LEU E 324 UNP P0DTC2 EXPRESSION TAG SEQADV 7FDG VAL E 325 UNP P0DTC2 EXPRESSION TAG SEQADV 7FDG LEU E 326 UNP P0DTC2 EXPRESSION TAG SEQADV 7FDG LEU E 327 UNP P0DTC2 EXPRESSION TAG SEQADV 7FDG PRO E 328 UNP P0DTC2 EXPRESSION TAG SEQADV 7FDG LEU E 329 UNP P0DTC2 EXPRESSION TAG SEQADV 7FDG VAL E 330 UNP P0DTC2 EXPRESSION TAG SEQADV 7FDG SER E 331 UNP P0DTC2 EXPRESSION TAG SEQADV 7FDG SER E 332 UNP P0DTC2 EXPRESSION TAG SEQADV 7FDG TYR E 501 UNP P0DTC2 ASN 501 ENGINEERED MUTATION SEQADV 7FDG HIS E 527 UNP P0DTC2 EXPRESSION TAG SEQADV 7FDG HIS E 528 UNP P0DTC2 EXPRESSION TAG SEQADV 7FDG HIS E 529 UNP P0DTC2 EXPRESSION TAG SEQADV 7FDG HIS E 530 UNP P0DTC2 EXPRESSION TAG SEQADV 7FDG HIS E 531 UNP P0DTC2 EXPRESSION TAG SEQADV 7FDG HIS E 532 UNP P0DTC2 EXPRESSION TAG SEQRES 1 A 621 MET SER SER SER SER TRP LEU LEU LEU SER LEU VAL ALA SEQRES 2 A 621 VAL THR ALA ALA GLN SER THR ILE GLU GLU GLN ALA LYS SEQRES 3 A 621 THR PHE LEU ASP LYS PHE ASN HIS GLU ALA GLU ASP LEU SEQRES 4 A 621 PHE TYR GLN SER SER LEU ALA SER TRP ASN TYR ASN THR SEQRES 5 A 621 ASN ILE THR GLU GLU ASN VAL GLN ASN MET ASN ASN ALA SEQRES 6 A 621 GLY ASP LYS TRP SER ALA PHE LEU LYS GLU GLN SER THR SEQRES 7 A 621 LEU ALA GLN MET TYR PRO LEU GLN GLU ILE GLN ASN LEU SEQRES 8 A 621 THR VAL LYS LEU GLN LEU GLN ALA LEU GLN GLN ASN GLY SEQRES 9 A 621 SER SER VAL LEU SER GLU ASP LYS SER LYS ARG LEU ASN SEQRES 10 A 621 THR ILE LEU ASN THR MET SER THR ILE TYR SER THR GLY SEQRES 11 A 621 LYS VAL CYS ASN PRO ASP ASN PRO GLN GLU CYS LEU LEU SEQRES 12 A 621 LEU GLU PRO GLY LEU ASN GLU ILE MET ALA ASN SER LEU SEQRES 13 A 621 ASP TYR ASN GLU ARG LEU TRP ALA TRP GLU SER TRP ARG SEQRES 14 A 621 SER GLU VAL GLY LYS GLN LEU ARG PRO LEU TYR GLU GLU SEQRES 15 A 621 TYR VAL VAL LEU LYS ASN GLU MET ALA ARG ALA ASN HIS SEQRES 16 A 621 TYR GLU ASP TYR GLY ASP TYR TRP ARG GLY ASP TYR GLU SEQRES 17 A 621 VAL ASN GLY VAL ASP GLY TYR ASP TYR SER ARG GLY GLN SEQRES 18 A 621 LEU ILE GLU ASP VAL GLU HIS THR PHE GLU GLU ILE LYS SEQRES 19 A 621 PRO LEU TYR GLU HIS LEU HIS ALA TYR VAL ARG ALA LYS SEQRES 20 A 621 LEU MET ASN ALA TYR PRO SER TYR ILE SER PRO ILE GLY SEQRES 21 A 621 CYS LEU PRO ALA HIS LEU LEU GLY ASP MET TRP GLY ARG SEQRES 22 A 621 PHE TRP THR ASN LEU TYR SER LEU THR VAL PRO PHE GLY SEQRES 23 A 621 GLN LYS PRO ASN ILE ASP VAL THR ASP ALA MET VAL ASP SEQRES 24 A 621 GLN ALA TRP ASP ALA GLN ARG ILE PHE LYS GLU ALA GLU SEQRES 25 A 621 LYS PHE PHE VAL SER VAL GLY LEU PRO ASN MET THR GLN SEQRES 26 A 621 GLY PHE TRP GLU ASN SER MET LEU THR ASP PRO GLY ASN SEQRES 27 A 621 VAL GLN LYS ALA VAL CYS HIS PRO THR ALA TRP ASP LEU SEQRES 28 A 621 GLY LYS GLY ASP PHE ARG ILE LEU MET CYS THR LYS VAL SEQRES 29 A 621 THR MET ASP ASP PHE LEU THR ALA HIS HIS GLU MET GLY SEQRES 30 A 621 HIS ILE GLN TYR ASP MET ALA TYR ALA ALA GLN PRO PHE SEQRES 31 A 621 LEU LEU ARG ASN GLY ALA ASN GLU GLY PHE HIS GLU ALA SEQRES 32 A 621 VAL GLY GLU ILE MET SER LEU SER ALA ALA THR PRO LYS SEQRES 33 A 621 HIS LEU LYS SER ILE GLY LEU LEU SER PRO ASP PHE GLN SEQRES 34 A 621 GLU ASP ASN GLU THR GLU ILE ASN PHE LEU LEU LYS GLN SEQRES 35 A 621 ALA LEU THR ILE VAL GLY THR LEU PRO PHE THR TYR MET SEQRES 36 A 621 LEU GLU LYS TRP ARG TRP MET VAL PHE LYS GLY GLU ILE SEQRES 37 A 621 PRO LYS ASP GLN TRP MET LYS LYS TRP TRP GLU MET LYS SEQRES 38 A 621 ARG GLU ILE VAL GLY VAL VAL GLU PRO VAL PRO HIS ASP SEQRES 39 A 621 GLU THR TYR CYS ASP PRO ALA SER LEU PHE HIS VAL SER SEQRES 40 A 621 ASN ASP TYR SER PHE ILE ARG TYR TYR THR ARG THR LEU SEQRES 41 A 621 TYR GLN PHE GLN PHE GLN GLU ALA LEU CYS GLN ALA ALA SEQRES 42 A 621 LYS HIS GLU GLY PRO LEU HIS LYS CYS ASP ILE SER ASN SEQRES 43 A 621 SER THR GLU ALA GLY GLN LYS LEU PHE ASN MET LEU ARG SEQRES 44 A 621 LEU GLY LYS SER GLU PRO TRP THR LEU ALA LEU GLU ASN SEQRES 45 A 621 VAL VAL GLY ALA LYS ASN MET ASN VAL ARG PRO LEU LEU SEQRES 46 A 621 ASN TYR PHE GLU PRO LEU PHE THR TRP LEU LYS ASP GLN SEQRES 47 A 621 ASN LYS ASN SER PHE VAL GLY TRP SER THR ASP TRP SER SEQRES 48 A 621 PRO TYR ALA ASP HIS HIS HIS HIS HIS HIS SEQRES 1 E 213 MET PHE VAL PHE LEU VAL LEU LEU PRO LEU VAL SER SER SEQRES 2 E 213 THR ASN LEU CYS PRO PHE GLY GLU VAL PHE ASN ALA THR SEQRES 3 E 213 ARG PHE ALA SER VAL TYR ALA TRP ASN ARG LYS ARG ILE SEQRES 4 E 213 SER ASN CYS VAL ALA ASP TYR SER VAL LEU TYR ASN SER SEQRES 5 E 213 ALA SER PHE SER THR PHE LYS CYS TYR GLY VAL SER PRO SEQRES 6 E 213 THR LYS LEU ASN ASP LEU CYS PHE THR ASN VAL TYR ALA SEQRES 7 E 213 ASP SER PHE VAL ILE ARG GLY ASP GLU VAL ARG GLN ILE SEQRES 8 E 213 ALA PRO GLY GLN THR GLY LYS ILE ALA ASP TYR ASN TYR SEQRES 9 E 213 LYS LEU PRO ASP ASP PHE THR GLY CYS VAL ILE ALA TRP SEQRES 10 E 213 ASN SER ASN ASN LEU ASP SER LYS VAL GLY GLY ASN TYR SEQRES 11 E 213 ASN TYR LEU TYR ARG LEU PHE ARG LYS SER ASN LEU LYS SEQRES 12 E 213 PRO PHE GLU ARG ASP ILE SER THR GLU ILE TYR GLN ALA SEQRES 13 E 213 GLY SER THR PRO CYS ASN GLY VAL GLU GLY PHE ASN CYS SEQRES 14 E 213 TYR PHE PRO LEU GLN SER TYR GLY PHE GLN PRO THR TYR SEQRES 15 E 213 GLY VAL GLY TYR GLN PRO TYR ARG VAL VAL VAL LEU SER SEQRES 16 E 213 PHE GLU LEU LEU HIS ALA PRO ALA THR VAL CYS GLY HIS SEQRES 17 E 213 HIS HIS HIS HIS HIS HET NAG A 701 14 HET NAG A 702 14 HET NAG A 703 14 HET NAG A 704 14 HET NAG E 601 14 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 3 NAG 5(C8 H15 N O6) HELIX 1 AA1 THR A 20 ASN A 53 1 34 HELIX 2 AA2 THR A 55 GLN A 81 1 27 HELIX 3 AA3 ASN A 90 GLN A 102 1 13 HELIX 4 AA4 ASN A 103 LEU A 108 5 6 HELIX 5 AA5 SER A 109 GLY A 130 1 22 HELIX 6 AA6 PRO A 146 ASN A 154 1 9 HELIX 7 AA7 ASP A 157 VAL A 172 1 16 HELIX 8 AA8 VAL A 172 ASN A 194 1 23 HELIX 9 AA9 ASP A 198 GLY A 205 1 8 HELIX 10 AB1 SER A 218 TYR A 252 1 35 HELIX 11 AB2 TRP A 275 THR A 282 1 8 HELIX 12 AB3 VAL A 293 GLN A 300 1 8 HELIX 13 AB4 ASP A 303 SER A 317 1 15 HELIX 14 AB5 THR A 324 SER A 331 1 8 HELIX 15 AB6 THR A 365 TYR A 385 1 21 HELIX 16 AB7 PRO A 389 ARG A 393 5 5 HELIX 17 AB8 GLY A 399 ALA A 413 1 15 HELIX 18 AB9 THR A 414 ILE A 421 1 8 HELIX 19 AC1 ASP A 431 VAL A 447 1 17 HELIX 20 AC2 GLY A 448 LYS A 465 1 18 HELIX 21 AC3 PRO A 469 ASP A 471 5 3 HELIX 22 AC4 GLN A 472 ILE A 484 1 13 HELIX 23 AC5 CYS A 498 SER A 502 5 5 HELIX 24 AC6 LEU A 503 ASN A 508 1 6 HELIX 25 AC7 PHE A 512 ALA A 533 1 22 HELIX 26 AC8 PRO A 538 CYS A 542 5 5 HELIX 27 AC9 SER A 547 ARG A 559 1 13 HELIX 28 AD1 PRO A 565 GLY A 575 1 11 HELIX 29 AD2 VAL A 581 ASN A 599 1 19 HELIX 30 AD3 PHE E 338 ASN E 343 1 6 HELIX 31 AD4 SER E 349 TRP E 353 5 5 HELIX 32 AD5 ASP E 364 SER E 371 1 8 HELIX 33 AD6 ASP E 405 ILE E 410 5 6 HELIX 34 AD7 GLY E 416 TYR E 421 1 6 HELIX 35 AD8 SER E 438 SER E 443 1 6 SHEET 1 AA1 2 LYS A 131 CYS A 133 0 SHEET 2 AA1 2 CYS A 141 LEU A 143 -1 O LEU A 142 N VAL A 132 SHEET 1 AA2 2 LEU A 262 PRO A 263 0 SHEET 2 AA2 2 VAL A 487 VAL A 488 1 O VAL A 488 N LEU A 262 SHEET 1 AA3 2 THR A 347 GLY A 352 0 SHEET 2 AA3 2 ASP A 355 LEU A 359 -1 O LEU A 359 N THR A 347 SHEET 1 AA4 5 ASN E 354 ILE E 358 0 SHEET 2 AA4 5 ASN E 394 ARG E 403 -1 O ALA E 397 N LYS E 356 SHEET 3 AA4 5 PRO E 507 GLU E 516 -1 O VAL E 512 N ASP E 398 SHEET 4 AA4 5 CYS E 432 ASN E 437 -1 N ILE E 434 O VAL E 511 SHEET 5 AA4 5 THR E 376 CYS E 379 -1 N THR E 376 O ALA E 435 SHEET 1 AA5 2 LEU E 452 ARG E 454 0 SHEET 2 AA5 2 LEU E 492 SER E 494 -1 O GLN E 493 N TYR E 453 SHEET 1 AA6 2 TYR E 473 GLN E 474 0 SHEET 2 AA6 2 CYS E 488 TYR E 489 -1 O TYR E 489 N TYR E 473 SSBOND 1 CYS A 133 CYS A 141 1555 1555 2.04 SSBOND 2 CYS A 344 CYS A 361 1555 1555 2.03 SSBOND 3 CYS A 530 CYS A 542 1555 1555 2.02 SSBOND 4 CYS E 336 CYS E 361 1555 1555 2.04 SSBOND 5 CYS E 379 CYS E 432 1555 1555 2.04 SSBOND 6 CYS E 391 CYS E 525 1555 1555 2.02 SSBOND 7 CYS E 480 CYS E 488 1555 1555 2.03 LINK ND2 ASN A 53 C1 NAG A 702 1555 1555 1.43 LINK ND2 ASN A 90 C1 NAG A 704 1555 1555 1.44 LINK ND2 ASN A 322 C1 NAG A 701 1555 1555 1.43 LINK ND2 ASN A 546 C1 NAG A 703 1555 1555 1.44 LINK ND2 ASN E 343 C1 NAG E 601 1555 1555 1.45 CISPEP 1 GLU A 145 PRO A 146 0 -3.20 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000